Penumbra (PEN) Profit After Tax Growth (1y) (2015 - 2026)
Penumbra (PEN) Profit After Tax Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 4.70% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -27.13% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 89.28% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 51.30% |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | -16.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.93% |
| Dec 31, 2025 | 40.55% |
| Sep 30, 2025 | 55.28% |
| Jun 30, 2025 | 175.20% |
| Mar 31, 2025 | 256.51% |
| Dec 31, 2024 | -37.87% |
| Sep 30, 2024 | 220.46% |
| Jun 30, 2024 | -417.51% |
| Mar 31, 2024 | 28.50% |
| Dec 31, 2023 | 1,298.45% |
| Sep 30, 2023 | 505.72% |
| Jun 30, 2023 | 614.24% |
| Mar 31, 2023 | 10,737.97% |
| Dec 31, 2022 | 115.74% |
| Sep 30, 2022 | -125.66% |
| Jun 30, 2022 | -144.43% |
| Mar 31, 2022 | -99.33% |
| Dec 31, 2021 | -775.25% |
| Sep 30, 2021 | 189.61% |
| Jun 30, 2021 | 169.39% |